Acute Leukemia Comprehensive Panel

11,000.00

The Acute Leukemia Comprehensive Panel is an extensive set of laboratory tests designed to diagnose, classify, and monitor acute leukemia. This panel includes a complete blood count (CBC) with differential, peripheral blood smear, bone marrow aspiration and biopsy, immunophenotyping (flow cytometry), cytogenetic and molecular genetic analyses. These tests together provide detailed information about the type and genetic characteristics of leukemia cells, which is crucial for personalized treatment planning.

Enquiry Here

    Description

    Why It’s Done:

    • To accurately diagnose acute leukemia and differentiate between subtypes such as acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
    • To identify genetic mutations or chromosomal abnormalities that influence prognosis and treatment options.
    • To guide selection of targeted therapies or chemotherapy regimens.
    • To monitor disease progression or remission during and after treatment.
    • To detect minimal residual disease or relapse early.

    Preparation:

    • Blood tests typically require no special preparation; fasting is usually not necessary.
    • Bone marrow aspiration/biopsy may require fasting for several hours prior and avoidance of certain medications, as directed by your healthcare provider.
    • Inform your healthcare provider about any medications, allergies, or medical conditions before testing.
    • Follow any specific instructions provided by your medical team regarding the bone marrow procedure.